Formoterolo Viatris may be available in the countries listed below.
Formoterol fumarate dihydrate (a derivative of Formoterol) is reported as an ingredient of Formoterolo Viatris in the following countries:
International Drug Name Search
Generic Name: fibrinogen (fye BRIN oh gen)
Brand Names: RiaSTAP
Fibrinogen is a man-made form of a protein that occurs naturally in the body and helps the blood clot.
Fibrinogen is used to treat bleeding episodes in people who have a congenital fibrinogen deficiency.
Fibrinogen may also be used for other purposes not listed in this medication guide.
If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before using fibrinogen, tell your doctor if you have a history of stroke or blood clot.
Do not self-inject this medicine if you do not fully understand how to give the injection and properly dispose of needles, IV tubing, and other items used in giving the medicine. This medication comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.
If you are using the injections at home, be sure you understand how to properly mix and store the medication. Do not mix the medicine until you are ready to give the injection.
Other serious side effects may include sudden numbness or weakness, chest pain, confusion, pain or swelling in your one or both legs, and problems with vision, speech, or balance.
Fibrinogen is made from human plasma (part of the blood) and may contain viruses and other infectious agents that can cause disease. Although donated human plasma is screened, tested, and treated to reduce the risk of it containing anything that could cause disease, there is still a small possibility it could transmit disease. Talk with your doctor about the risks and benefits of using this medication.
If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before using fibrinogen, tell your doctor if you have a history of stroke or blood clot.
Fibrinogen is made from human plasma (part of the blood) and may contain viruses and other infectious agents that can cause disease. Although donated human plasma is screened, tested, and treated to reduce the risk of it containing anything that could cause disease, there is still a small possibility it could transmit disease. Talk with your doctor about the risks and benefits of using this medication.
Fibrinogen is given as an injection through a needle placed into a vein. Your doctor, nurse, or other healthcare provider will give you this injection. You may be shown how to use your medicine at home. Do not self-inject this medicine if you do not fully understand how to give the injection and properly dispose of needles, IV tubing, and other items used in giving the medicine.
You will need to mix fibrinogen with a liquid (diluent) before using it. If you are using the injections at home, be sure you understand how to properly mix and store the medication. Do not mix fibrinogen with any other medicines, or give other medicines through the same IV line.
Each single-use vial (bottle) of this medicine is for one use only. Throw away the vial after one use, even if there is still some medicine left in it after injecting your dose.
To be sure this medication is helping your condition, your blood may need to be tested often. This will help your doctor determine how long to treat you with fibrinogen. Do not miss any follow-up visits to your doctor.
Use each disposable needle only one time. Throw away used needles in a puncture-proof container (ask your pharmacist where you can get one and how to dispose of it). Keep this container out of the reach of children and pets.
Use the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to use the medicine and skip the missed dose. Do not use extra medicine to make up the missed dose.
Symptoms of a fibrinogen overdose are not known.
Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using fibrinogen.
sudden numbness or weakness, especially on one side of the body;
sudden headache, confusion, problems with vision, speech, or balance;
sudden cough, rapid breathing, fast heart rate;
chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling; or
pain or swelling in one or both legs.
Less serious side effects may include:
fever
chills;
nausea; or
vomiting.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
There may be other drugs that can interact with fibrinogen. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.
See also: RiaSTAP side effects (in more detail)
Lisinopril comp. Heumann may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Lisinopril comp. Heumann in the following countries:
Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril comp. Heumann in the following countries:
International Drug Name Search
Fenuril may be available in the countries listed below.
Urea is reported as an ingredient of Fenuril in the following countries:
International Drug Name Search
Tamsuna may be available in the countries listed below.
Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Tamsuna in the following countries:
International Drug Name Search
Zeplan may be available in the countries listed below.
Simvastatin is reported as an ingredient of Zeplan in the following countries:
International Drug Name Search
Elotaxin may be available in the countries listed below.
Oxaliplatin is reported as an ingredient of Elotaxin in the following countries:
International Drug Name Search
Fenicol may be available in the countries listed below.
Chloramphenicol is reported as an ingredient of Fenicol in the following countries:
International Drug Name Search
Gen-Fosinopril may be available in the countries listed below.
Fosinopril sodium salt (a derivative of Fosinopril) is reported as an ingredient of Gen-Fosinopril in the following countries:
International Drug Name Search
Gliclazida Labesfal may be available in the countries listed below.
Gliclazide is reported as an ingredient of Gliclazida Labesfal in the following countries:
International Drug Name Search
Paroxetin Spirig may be available in the countries listed below.
Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Paroxetin Spirig in the following countries:
International Drug Name Search
Ramigamma HCT may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Ramigamma HCT in the following countries:
Ramipril is reported as an ingredient of Ramigamma HCT in the following countries:
International Drug Name Search
Lutamidal may be available in the countries listed below.
Bicalutamide is reported as an ingredient of Lutamidal in the following countries:
International Drug Name Search
Vagimen may be available in the countries listed below.
Clotrimazole is reported as an ingredient of Vagimen in the following countries:
International Drug Name Search
Garmastan may be available in the countries listed below.
Guaiazulene is reported as an ingredient of Garmastan in the following countries:
International Drug Name Search
Gaap may be available in the countries listed below.
Latanoprost is reported as an ingredient of Gaap in the following countries:
International Drug Name Search
0000472-11-7
C27-H42-O4
430
Antihemorrhoidal agent
Spirost-5-ene-1,3-diol, (1ß,3ß,25R)-
International Drug Name Search
